Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1989 4
1990 5
1991 1
1992 1
1998 1
1999 1
2008 3
2010 1
2011 1
2012 1
2013 1
2014 1
2015 1
2018 2
2019 1
2024 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

25 results

Results by year

Filters applied: . Clear all
Page 1
Dolutegravir plus lamivudine versus dolutegravir plus tenofovir disoproxil fumarate and emtricitabine in antiretroviral-naive adults with HIV-1 infection (GEMINI-1 and GEMINI-2): week 48 results from two multicentre, double-blind, randomised, non-inferiority, phase 3 trials.
Cahn P, Madero JS, Arribas JR, Antinori A, Ortiz R, Clarke AE, Hung CC, Rockstroh JK, Girard PM, Sievers J, Man C, Currie A, Underwood M, Tenorio AR, Pappa K, Wynne B, Fettiplace A, Gartland M, Aboud M, Smith K; GEMINI Study Team. Cahn P, et al. Lancet. 2019 Jan 12;393(10167):143-155. doi: 10.1016/S0140-6736(18)32462-0. Epub 2018 Nov 9. Lancet. 2019. PMID: 30420123 Clinical Trial.
Higher COVID-19 pneumonia risk associated with anti-IFN-α than with anti-IFN-ω auto-Abs in children.
Bastard P, Gervais A, Taniguchi M, Saare L, Särekannu K, Le Voyer T, Philippot Q, Rosain J, Bizien L, Asano T, Garcia-Prat M, Parra-Martínez A, Migaud M, Tsumura M, Conti F, Belot A, Rivière JG, Morio T, Tanaka J, Javouhey E, Haerynck F, Duvlis S, Ozcelik T, Keles S, Tandjaoui-Lambiotte Y, Escoda S, Husain M, Pan-Hammarström Q, Hammarström L, Ahlijah G, Abi Haidar A, Soudee C, Arseguel V, Abolhassani H, Sahanic S, Tancevski I, Nukui Y, Hayakawa S, Chrousos GP, Michos A, Tatsi EB, Filippatos F, Rodriguez-Palmero A, Troya J, Tipu I, Meyts I, Roussel L, Ostrowski SR, Schidlowski L, Prando C, Condino-Neto A, Cheikh N, Bousfiha AA, El Bakkouri J; COVID Clinicians; GEN-COVID Study Group; COVID Human Genetic Effort; Peterson P, Pujol A, Lévy R, Quartier P, Vinh DC, Boisson B, Béziat V, Zhang SY, Borghesi A, Pession A, Andreakos E, Marr N, Mentis AA, Mogensen TH, Rodríguez-Gallego C, Soler-Palacin P, Colobran R, Tillmann V, Neven B, Trouillet-Assant S, Brodin P, Abel L, Jouanguy E, Zhang Q, Martinón-Torres F, Salas A, Gómez-Carballa A, Gonzalez-Granado LI, Kisand K, Okada S, Puel A, Cobat A, Casanova JL. Bastard P, et al. J Exp Med. 2024 Feb 5;221(2):e20231353. doi: 10.1084/jem.20231353. Epub 2024 Jan 4. J Exp Med. 2024. PMID: 38175961 Free PMC article.
[Safety and tolerability of darunavir].
Antela López A. Antela López A. Enferm Infecc Microbiol Clin. 2008 Oct;26 Suppl 10:32-6. doi: 10.1016/s0213-005x(08)76551-0. Enferm Infecc Microbiol Clin. 2008. PMID: 19195457 Review. Spanish.
[Consensus statement on the clinical management of human immunodeficiency virus-associated neurocognitive disorders].
Grupo de expertos del Grupo de Estudio de Sida (GeSIDA) y de la Secretaría del Plan Nacional sobre el Sida (SPNS); Podzamczer Palter D, Muñoz-Moreno JA, Alcolea Rodríguez D, Alonso Villaverde C, Antela López A, Blanch Andreu J, Casado Osorio JL, Galindo Puerto MJ, Garolera i Freixa M, Locutura Rupérez J, Lleó Bisa A, Prats París A, Pérez-Valero I, Portilla Sogorb J, Rovira Cañellas A, Téllez Molina MJ, Tiraboschi JM, Vergara Moragues E, Arribas López JR, Goenaga Sánchez MÁ, de León-Naranjo FL, Martínez Chamorro E, Polo Rodríguez R, Muñoz-Moreno JA, Podzamczer D. Grupo de expertos del Grupo de Estudio de Sida (GeSIDA) y de la Secretaría del Plan Nacional sobre el Sida (SPNS), et al. Among authors: antela lopez a. Enferm Infecc Microbiol Clin. 2014 Jan;32(1):37-47. doi: 10.1016/j.eimc.2013.03.005. Epub 2013 Apr 30. Enferm Infecc Microbiol Clin. 2014. PMID: 23642283 Spanish.
[Utility of atazanavir in special populations].
Antela López A. Antela López A. Enferm Infecc Microbiol Clin. 2008 Dec;26 Suppl 17:49-54. doi: 10.1016/S0213-005X(08)76621-7. Enferm Infecc Microbiol Clin. 2008. PMID: 20116618 Review. Spanish.
[The POEMS syndrome].
Antela López A, Requena Caballero I, Masa Vázquez L, Antela Carrera C, Barrio Gómez E. Antela López A, et al. An Med Interna. 1989 Aug;6(8):439-42. An Med Interna. 1989. PMID: 2491091 Review. Spanish.
[Plasmacytoma of the thyroid. A review apropos a case].
Tomé Martínez de Rituerto S, Antela López A, García Rodríguez J, Batalla Eiras A, Antúnez López J, Rodríguez López I, Torre Carballada JA. Tomé Martínez de Rituerto S, et al. Among authors: antela lopez a. An Med Interna. 1991 Oct;8(10):503-5. An Med Interna. 1991. PMID: 1751692 Review. Spanish.
[Duodenocolonic fistula caused by carcinoma of the cecum].
García Rodríguez JF, Antela López A, Tomé Martínez de Rituerto S, Martínez Vázquez F, Antela Carrera C, Barrio Gómez E. García Rodríguez JF, et al. Among authors: antela lopez a. Rev Esp Enferm Apar Dig. 1989 Jul;76(1):79-81. Rev Esp Enferm Apar Dig. 1989. PMID: 2678321 Review. Spanish.
Late initiation of HAART among HIV-infected patients in Spain is frequent and related to a higher rate of virological failure but not to immigrant status.
Pérez-Molina JA, Suárez-Lozano I, Del Arco A, Teira R, Bachiller P, Pedrol E, Martínez-Alfaro E, Domingo P, Mariño A, Ribera E, Antela A, de Otero J, Navarro V, González-García J; Gesida 5808 Study Group. Pérez-Molina JA, et al. HIV Clin Trials. 2011 Jan-Feb;12(1):1-8. doi: 10.1310/hct1201-1. HIV Clin Trials. 2011. PMID: 21388936
25 results